Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Stock-based Compensation

v3.19.3
Note 10 - Stock-based Compensation
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
Note
10:
Stock-Based Compensation
 
 
The Company grants stock-based awards under its
2014
Incentive Stock Plan (the
“2014
Plan”) and the
2012
Stock Plan (the
“2012
Plan”). The
2014
Plan replaced the
2012
Plan, but the
2012
plan remains in effect for the administration of awards made prior to its replacement by the
2014
Plan. The shares issued as a result of stock-based compensation transactions generally have been funded with the issuance of new shares of the Company’s common stock.
 
The Company
may
grant the following types of incentive awards under the
2014
Plan: (i) non-qualified stock options; (ii) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; and (v) restricted stock units. Each award granted under the
2014
Plan is subject to an award agreement that incorporates, as applicable, the exercise price, the term of the award, the periods of restriction, the number of shares to which the award pertains, and such other terms and conditions as the plan committee determines. Awards granted under the
2014
Plan are classified as equity awards, which are recorded in stockholders’ equity in the Company’s Consolidated Balance Sheets.
  
 
Stock Options
 
The Company’s closing price on the date of grant is the basis of fair value of its common stock used in determining the value of share-based awards. To the extent the value of the Company’s share-based awards involves a measure of volatility, the Company historically relied on the volatilities from publicly-traded companies with similar business models as its common stock lacked enough trading history for it to utilize its own historical volatility. Effective
July 1, 2019,
the Company uses historical volatility of the Company’s common stock over a period of time corresponding to the expected stock option term. The Company uses the simplified method to calculate the expected term of stock option grants to employees as the Company does
not
have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term of stock options granted to employees. Accordingly, the expected life of the options granted is based on the average of the vesting term, which is generally
four
years and the contractual term, which is generally
ten
years. The Company will continue to evaluate the appropriateness of utilizing such method. The risk-free interest rate is based on United States Treasury yields in effect at the date of grant for periods corresponding to the expected stock option term.
 
 
The Company has computed the fair value of all options granted during the
nine
months ended
September 30, 2019
and
2018,
using the following assumptions:
 
 
 
 
Nine Months Ended September 30,
 
 
 
 
2019
 
2018
 
 
Expected volatility
 
35%
to
55%
 
 
35%
 
 
 
Expected dividends
 
 
None
 
 
 
None
 
 
 
Expected term (years)
 
 
7
 
 
 
7
 
 
 
Risk-free rate
 
1.89%
to
2.61%
 
2.53%
to
2.90%
 
 
Forfeiture rate
 
 
20%
 
 
 
20%
 
 
 
The information below summarizes the stock options activity:
 
            Weighted
   
 
 
Weighted
 
Average
   
 
 
Average
 
Remaining
   
Number of
 
Exercise
 
Contractual Life
   
Shares
 
Price
 
(Years)
Outstanding at December 31, 2017    
1,003,916
 
  $
4.18
 
   
8.1
 
Granted    
145,792
 
   
7.00
 
   
 
 
Exercised    
(95,162
)
   
3.48
 
   
 
 
Cancelled    
(67,855
)
   
3.37
 
   
 
 
Outstanding at December 31, 2018    
986,691
 
  $
4.72
 
   
6.8
 
Granted    
65,759
 
   
12.31
 
   
 
 
Exercised    
(99,132
)
   
5.32
 
   
 
 
Cancelled    
-
 
   
-
 
   
 
 
Outstanding at September 30, 2019    
953,318
 
  $
5.19
 
   
6.8
 
Exercisable at September 30, 2019    
557,588
 
  $
4.48
 
   
6.1
 
 
The aggregate intrinsic value of the Company’s stock options outstanding and expected to vest was
$11,817,136
at
September 30, 2019.
 
The aggregate intrinsic value of the Company’s stock options exercisable was
$7,879,967
at
September 30, 2019.
 
For the
three
and
nine
months ended
September 30, 2019,
stock-based compensation expense for stock options was
$110,367
and
$307,017,
respectively.  For the
three
and
nine
months ended
September 30, 2018,
stock-based compensation expense for stock options was
$62,951
and
$271,764,
respectively. Unrecognized stock-based compensation expense for stock options as of
September 30, 2019
was
$840,547,
which is expected to be recognized ratably over the next
2.7
years.
 
Restricted Stock
 
Restricted stocks granted to employees generally vest in
four
equal annual installments. Restricted stocks granted to non-employee directors typically vest in full
one
year after the date of grant.
 
The information below summaries the restricted stock activity:
 
 
Restricted Stock Awards
 
Shares
 
 
Non-vested at December 31, 2018
 
 
51,134
 
 
 
Granted
 
 
26,131
 
 
 
Vested
 
 
(38,289
)
 
 
Cancelled
 
 
-  
 
 
 
Non-vested at September 30, 2019
 
 
38,976
 
 
 
For the
three
and
nine
months ended
September 30, 2019,
stock-based compensation expense for restricted stock was
$75,653
and
$229,727,
respectively. For the
three
and
nine
months ended
September 30, 2018,
stock-based compensation expense for restricted stock was
$59,825
and
$197,641,
respectively.
 
Unrecognized stock-based compensation expense for restricted stock awards as of
September 30, 2019
was
$393,653,
which is expected to be recognized ratably over the next
2.1
years.